Mesenchymal Stromal Cells Improve Response to Second-Line aGVHD Therapy
Researchers sought to determine whether adding MSC to basiliximab and a calcineurin inhibitor would improve outcomes in patients with aGVHD after HSCT.
Researchers sought to determine whether adding MSC to basiliximab and a calcineurin inhibitor would improve outcomes in patients with aGVHD after HSCT.
Researchers sought to improve the understanding of cGVHD in pediatric patients with ALL after they receive allo-HSCT.
The aim of this study was to evaluate the outcomes of pediatric patients who develop SR-aGVHD during a 10-year time period.
Researchers sought to determine whether plasma alpha-ketoglutaric acid is elevated in pediatric patients who develop cGVHD.
Researchers sought to determine whether ofatumumab in combination with prednisone would be safe and effective as initial therapy in chronic GVHD.
Researchers sought to determine whether depleting naïve T cells from PBSC allografts may reduce the risk of severe acute or chronic GVHD in patients undergoing HCT.
Researchers sought to determine whether there is a link between beta-blockers with GVHD in patients receiving allogeneic hematopoietic stem cell transplantation.
Researchers sought to determine whether belumosudil would be an effective treatment for patients who develop chronic graft vs host disease after 2 or more lines of therapy.
Extended time interval identified between diagnosis of ocular graft-vs-host disease and corneal perforation.
Researchers sought to determine whether transplantation with omidubicel may yield faster platelet recovery in patients with hematologic malignancies compared with UCBT.